Tenecteplase for Acute Stroke

Description

With the nod that tenecteplase received in the most recent AHA/ASA acute stroke guidelines, many hospitals have begun making the switch from alteplase to tenecteplase.

After this webinar participants will be able to:

• Discuss the history of tenecteplase in acute stroke
• Explain the latest research and evidence around tenecteplase
• Describe one system’s journey to making this major practice change

About the Presenter

Dr. Matthew Grantz is a board-certified vascular neurologist. He practices in the state of Utah where he is the stroke medical director for St Mark’s Hospital and serves on the Utah State Stroke Task Force. Dr. Grantz is a telestroke provider for Blue Sky Telehealth.

CME Information:

This activity has been approved for AMA PRA Category 1 Credit(s)TM.

• Release Date: 2/25/22
• Expiration Date: 2/25/23
• Estimated time to complete this activity is 1 hour.